Welcome to Sequence Card of Peptide


Details of CPPsite entry with Sequence RRRRRR
Primary information
PEPTIDE SEQUENCERRRRRR
CPPsite ID 2532, 2533, 1032,
PEPTIDE NAMEV2, V2R, R6
CHIRALITYL, L, L
LINEAR/CYCLICLinear, Linear, Linear
SOURCESynthetic, Synthetic, Synthetic
CATEGORYCationic, Cationic, Cationic
SUB CELLULAR LOCALIZATIONCytoplasm and Nucleus, NA, Cytoplasm and nucleus
N-TERMINAL MODIFICATIONConjugated to FITC modified folding domain via ?-alanine–glycine– glycine linker, Conjugated to FITC modified folding domain via ?-alanine–glycine– glycine linker, Conjugation with fluorescein with 6-aminohexanoic acid (Ahx) spacer
C-TERMINAL MODIFICATIONAmidation, Amidation, Free
CHEMICAL MODIFICATIONNA, NA, NA
UPTAKE EFFICIENCYV2 has a stronger preference to accumulate within the nuclear bodies that contain a high con- centration of DNA, Cells indicates a lack of cellular uptake of V2R, Medium (relative to Tat (49-57))
PROPOSED UPTAKE MECHANISMNA, NA, Probably non-endocytic pathway
INVITRO/INVIVOIn vitro, In vitro, In vitro
CELL LINENIH-3T3 Swiss mice fibroblasts and Jurkat E6 cells, NIH-3T3 Swiss mice fibroblasts and Jurkat E6 cells, Jurkat
In VIVO MODELNA, NA, NA
CARGOPeptide (FITC labelled peptide), Peptide (FITC labelled peptide), Fluorophore (fluorescein)
PMID25524829, 25524829, 11087855
PATENTUnknown, Unknown, US 6593292
Tertiary Structure
(Technique)
2532 (PEPstrMOD), 2533 (PEPstrMOD), 1032 (PEPstrMOD),